AM2201 (Item No. 10707) is an analytical reference material characterized as a synthetic cannabinoid. AM2201 is regulated as a Schedule I compound in the United States. This product is intended for research and forensic applications.
It is a drug which acts as a potent but unselective agonist for the cannabinoid receptor CB1 or CB2.
AM2201 is a potent synthetic cannabinoid (CB) with Ki values of 1.0 and 2.6 nM for the CB1 and CB2 receptors, respectively. The physiological actions and metabolism of AM2201 have not been characterized. This product is a qualified Reference Material (RM) that has been manufactured and tested to meet ISO17025 and Guide 34 guidelines. These materials are tested using validated analytical methods on qualified instrumentation to ensure traceability of measurements. All traceable RMs may be distinguished by their CofAs and can be downloaded below using the batch number located on the product label. For a representative CofA please contact our technical support.[Cayman Chemical]
ChEBI: AM2201 is an indolecarboxamide.
